Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott Kim

Showing results (11-20 of 98) with videos related to

Pageof 10
Sort By:
Neural Regeneration Research|January 17, 2025
ABCA5 lipid transporter is associated with a reduced risk of Parkinson's diseaseJasmin Galper, Nicolas Dzamko, Woojin Scott Kim
Neural Regeneration Research|February 5, 2026
Recognizing Alzheimer's disease and Parkinson's disease as astrogliopathiesWoojin Scott Kim, Onur Tanglay, YuHong Fu
Nature|January 30, 2009
Pruning the regulatory treeScott Kim, Peter Ubel, Raymond De Vries
Neuroreport|October 9, 2008
Regulation of alpha-synuclein expression by liver X receptor ligands in vitroDanni Cheng, Woojin Scott Kim, Brett Garner
Current Vascular Pharmacology|April 14, 2006
Fine tuning therapeutic targeting of the sphingolipid biosynthetic pathway to treat atherosclerosisW Scott Kim, Charles E Chalfant, Brett Garner
Journal of Neurochemistry|November 2, 2007
Role of ATP-binding cassette transporters in brain lipid transport and neurological diseaseWoojin Scott Kim, Cynthia Shannon Weickert, Brett Garner
Alzheimer'S Research & Therapy|January 13, 2015
Alpha-synuclein biology in Lewy body diseasesWoojin Scott Kim, Katarina Kågedal, Glenda M Halliday
Organic Letters|February 13, 2019
Copper-Catalyzed Aminoboration from Hydrazones To Generate Borylated PyrazolesKim N Tu, Scott Kim, Suzanne A Blum
Biochemical and Biophysical Research Communications|October 3, 2003
Activation of signaling pathways by putative scavenger receptor class A (SR-A) ligands requires CD14 but not SR-AWoojin Scott Kim, Christine M Ordija, Mason W Freeman
Acta Neuropathologica Communications|February 11, 2016
Animal modeling an oligodendrogliopathy--multiple system atrophyJonathan M Bleasel, Glenda M Halliday, Woojin Scott Kim
Pageof 10

Showing results (11-20 of 98) with videos related to

Sort By:
Pageof 10
Neural Regeneration Research|January 17, 2025
ABCA5 lipid transporter is associated with a reduced risk of Parkinson's diseaseJasmin Galper, Nicolas Dzamko, Woojin Scott Kim
Neural Regeneration Research|February 5, 2026
Recognizing Alzheimer's disease and Parkinson's disease as astrogliopathiesWoojin Scott Kim, Onur Tanglay, YuHong Fu
Nature|January 30, 2009
Pruning the regulatory treeScott Kim, Peter Ubel, Raymond De Vries
Neuroreport|October 9, 2008
Regulation of alpha-synuclein expression by liver X receptor ligands in vitroDanni Cheng, Woojin Scott Kim, Brett Garner
Current Vascular Pharmacology|April 14, 2006
Fine tuning therapeutic targeting of the sphingolipid biosynthetic pathway to treat atherosclerosisW Scott Kim, Charles E Chalfant, Brett Garner
Journal of Neurochemistry|November 2, 2007
Role of ATP-binding cassette transporters in brain lipid transport and neurological diseaseWoojin Scott Kim, Cynthia Shannon Weickert, Brett Garner
Alzheimer'S Research & Therapy|January 13, 2015
Alpha-synuclein biology in Lewy body diseasesWoojin Scott Kim, Katarina Kågedal, Glenda M Halliday
Organic Letters|February 13, 2019
Copper-Catalyzed Aminoboration from Hydrazones To Generate Borylated PyrazolesKim N Tu, Scott Kim, Suzanne A Blum
Biochemical and Biophysical Research Communications|October 3, 2003
Activation of signaling pathways by putative scavenger receptor class A (SR-A) ligands requires CD14 but not SR-AWoojin Scott Kim, Christine M Ordija, Mason W Freeman
Acta Neuropathologica Communications|February 11, 2016
Animal modeling an oligodendrogliopathy--multiple system atrophyJonathan M Bleasel, Glenda M Halliday, Woojin Scott Kim
Pageof 10